It was reported on November 27, that Michael J Farrell, Chief Executive Officer at ResMed RMD executed a significant insider ...

Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...

Cerity Partners LLC increased its stake in ResMed Inc. (NYSE:RMD – Free Report) by 82.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The ...

ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. Meet the ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Christopher ...

Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...